市場調查報告書

降壓藥的全球市場分析:治療水準·各流通管道·各地區的未來預測

Global Antihypertensive Drugs Market Size study, by Therapeutic Class, by Distribution Channel and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 946923
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
降壓藥的全球市場分析:治療水準·各流通管道·各地區的未來預測 Global Antihypertensive Drugs Market Size study, by Therapeutic Class, by Distribution Channel and Regional Forecasts 2020-2027
出版日期: 2020年06月20日內容資訊: 英文
簡介

全球降壓藥市場在2019年估算達到2320萬美元的規模,2020∼2027年更將以3.1%以上的成長率增長。由於近來的新型冠狀病毒感染疾病 (Covid-19)感染擴大,建議通過讓患者服用降壓藥來避免與呼吸有關的風險,被認為是降壓藥市場增長的主要因素。

本報告提供全球降壓藥 (抗高血壓藥)的市場相關分析,彙整市場基本結構 (價值鏈等) 和主要的促進·阻礙因素,整體市場規模趨勢預測 (今後8年份),治療水準·各流通管道及地區別詳細趨勢,主要企業的簡介·市場佔有率等資訊,為您概述為以下內容。

第1章 摘要整理

第2章 全球降壓藥市場:定義和範圍

第3章 全球降壓藥市場:市場動態

  • 降壓藥對市場的影響要素分析

第4章 全球降壓藥市場:產業分析

  • 波特的五力分析
  • PEST分析
  • 投資/引進模式
  • 分析師的建議與結論

第5章 全球降壓藥市場:各治療水準

  • 市場概況
  • 市場實際成果,各治療水準:未來性分析
  • 市場估計值·預測值:各治療水準 (以金額為準)
  • 子區隔分析
    • 利尿劑
    • 血管收縮素轉化酵素(ACE)阻礙劑
    • 鈣通道阻滯劑
    • 血管擴張藥
    • β腎上腺素阻斷劑
    • 其他

第6章 全球降壓藥市場:各流通管道

  • 市場概況
  • 市場實際成果,各流通管道:未來性分析
  • 市場估計值·預測值:各流通管道 (以金額為準)
  • 子區隔分析
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第7章 全球降壓藥市場:各地區分析

  • 各地區的市場概況
  • 北美市場
    • 美國
    • 加拿大
  • 歐洲市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲各國
  • 亞太地區市場
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他的亞太地區各國
  • 南美市場
    • 巴西
    • 墨西哥
  • 其他的國家的市場 (RoW)

第8章 企業資料

  • 主要市場策略
  • 企業簡介
    • Boehringer Ingelheim International GmbH
    • Merck & Co., KGaA
    • Johnson and Johnson
    • Bayer AG
    • Pfizer, Inc.
    • 武田藥品工業
    • AstraZeneca plc
    • 第一三共
    • Sanofi S.A.
    • Novartis International AG

第9章 調查流程

目錄

Title:
Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027.

Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Antihypertensive drug is the class of drug used in the treatment of hypertension (high blood pressure). Hypertension is one of the leading causes of heart complications, such as heart failure, heart attack, and dementia. Thus, the treatment of hypertension must be integrated into an overall program to manage factors that intensify the risk of cardiovascular events (such as stroke and myocardial infarction). Therefore, there are a variety of antihypertensive drugs has been developed for treating hypertension. Some of the major antihypertensive drugs are thiazide diuretics, beta-adrenoceptor antagonists (beta-blockers), dihydropyridine calcium-channel blockers, and many more. These drugs can reduce the blood pressure rates and can prevent the health complications associated with high blood pressure. Therefore, these factors are anticipated to accelerate the market growth around the world. Moreover, the rise in cases of hypertension across the globe, followed by the growing elderly population are few other factors responsible for the market growth over the forecast period. According to the World Health Organization (WHO), around 1.3 billion people have hypertension around the world. Also, the possibility of its prevalence increases with age. As per the Framingham Heart Study, hypertension eventually developed in over 90% of participants with normal blood pressure at 55 years of age. By age 60 years of age, nearly 60% of the population has hypertension, by 70 years, about 65% of men and 75% of women have hypertension. This, in turn, is likely to accelerate the demand for drugs all over the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of drugs among the patients to prevent or mitigate the risk of respiratory-related problems. This is likely to strengthen the usage for antihypertensive drugs that encourage the manufacturers to produce them thereby, the market would grow at a significant rate in the forthcoming years. However, side-effects related to the use of drugs is one of the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antihypertensive Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rise in prevalence of hypertension, along with the significant initiatives opt by the market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising geriatric population and increasing incidences of heart attack and failures among people would create lucrative growth prospects for the Antihypertensive Drugs market across the Asia-Pacific region.

Major market player included in this report are:

Boehringer Ingelheim International GmbH

Merck & Co., KGaA

Johnson and Johnson

Bayer AG

Pfizer, Inc.

Takeda Pharmaceutical Co. Ltd.

AstraZeneca plc

Daiichi Sankyo Company, Ltd.

Sanofi S.A.

Novartis International AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class:

Diuretics

Angiotensin-Converting Enzyme (ACE) Inhibitors

Calcium Channel Blockers

Vasodilators

Beta-adrenergic Blockers

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Antihypertensive Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. Antihypertensive Drugs Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. Antihypertensive Drugs Market, by Therapeutic Class, 2018-2027 (USD Million)
    • 1.2.3. Antihypertensive Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antihypertensive Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antihypertensive Drugs Market Dynamics

  • 3.1. Antihypertensive Drugs Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Antihypertensive Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antihypertensive Drugs Market, by Therapeutic Class

  • 5.1. Market Snapshot
  • 5.2. Global Antihypertensive Drugs Market by Therapeutic Class, Performance - Potential Analysis
  • 5.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Therapeutic Class 2017-2027 (USD Million)
  • 5.4. Antihypertensive Drugs Market, Sub Segment Analysis
    • 5.4.1. Diuretics
    • 5.4.2. Angiotensin-Converting Enzyme (ACE) Inhibitors
    • 5.4.3. Calcium Channel Blockers
    • 5.4.4. Vasodilators
    • 5.4.5. Beta-adrenergic Blockers
    • 5.4.6. Others

Chapter 6. Global Antihypertensive Drugs Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Antihypertensive Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Million)
  • 6.4. Antihypertensive Drugs Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Retail Pharmacies
    • 6.4.3. Online Pharmacies

Chapter 7. Global Antihypertensive Drugs Market, Regional Analysis

  • 7.1. Antihypertensive Drugs Market, Regional Market Snapshot
  • 7.2. North America Antihypertensive Drugs Market
    • 7.2.1. U.S. Antihypertensive Drugs Market
      • 7.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Antihypertensive Drugs Market
  • 7.3. Europe Antihypertensive Drugs Market Snapshot
    • 7.3.1. U.K. Antihypertensive Drugs Market
    • 7.3.2. Germany Antihypertensive Drugs Market
    • 7.3.3. France Antihypertensive Drugs Market
    • 7.3.4. Spain Antihypertensive Drugs Market
    • 7.3.5. Italy Antihypertensive Drugs Market
    • 7.3.6. Rest of Europe Antihypertensive Drugs Market
  • 7.4. Asia-Pacific Antihypertensive Drugs Market Snapshot
    • 7.4.1. China Antihypertensive Drugs Market
    • 7.4.2. India Antihypertensive Drugs Market
    • 7.4.3. Japan Antihypertensive Drugs Market
    • 7.4.4. Australia Antihypertensive Drugs Market
    • 7.4.5. South Korea Antihypertensive Drugs Market
    • 7.4.6. Rest of Asia Pacific Antihypertensive Drugs Market
  • 7.5. Latin America Antihypertensive Drugs Market Snapshot
    • 7.5.1. Brazil Antihypertensive Drugs Market
    • 7.5.2. Mexico Antihypertensive Drugs Market
  • 7.6. Rest of The World Antihypertensive Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Boehringer Ingelheim International GmbH
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Merck & Co., KGaA
    • 8.2.3. Johnson and Johnson
    • 8.2.4. Bayer AG
    • 8.2.5. Pfizer, Inc.
    • 8.2.6. Takeda Pharmaceutical Co. Ltd.
    • 8.2.7. AstraZeneca plc
    • 8.2.8. Daiichi Sankyo Company, Ltd.
    • 8.2.9. Sanofi S.A.
    • 8.2.10. Novartis International AG

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

List of Tables

  • TABLE 1. Global Antihypertensive Drugs market, report scope
  • TABLE 2. Global Antihypertensive Drugs market estimates & forecasts by region 2017-2027 (USD Million)
  • TABLE 3. Global Antihypertensive Drugs market estimates & forecasts by Therapeutic Class 2017-2027 (USD Million)
  • TABLE 4. Global Antihypertensive Drugs market estimates & forecasts by Distribution Channel 2017-2027 (USD Million)
  • TABLE 5. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 6. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 7. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 8. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 9. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 10. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 11. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 12. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 13. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 14. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 15. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 16. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 17. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 18. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 19. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 20. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 21. U.S. Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 22. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 23. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 24. Canada Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 25. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 26. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 27. UK Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 28. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 29. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 30. Germany Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 31. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 32. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 33. France Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 34. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 35. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 36. Spain Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 37. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 38. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 39. Italy Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 40. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 41. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 42. ROE Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 43. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 44. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 45. China Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 46. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 47. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 48. India Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 49. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 50. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 51. Japan Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 52. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 53. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 54. Australia Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 55. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 56. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 57. South Korea Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 58. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 59. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 60. ROPAC Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 61. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 62. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 63. Brazil Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 64. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 65. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 66. Mexico Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 67. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 68. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 69. ROLA Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 70. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 71. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 72. ROW Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 73. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 74. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 75. List of secondary sources, used in the study of global Antihypertensive Drugs market
  • TABLE 76. List of primary sources, used in the study of global Antihypertensive Drugs market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Antihypertensive Drugs market, research methodology
  • FIG 2. Global Antihypertensive Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Antihypertensive Drugs market, key trends 2019
  • FIG 5. Global Antihypertensive Drugs market, growth prospects 2020-2027
  • FIG 6. Global Antihypertensive Drugs market, porters 5 force model
  • FIG 7. Global Antihypertensive Drugs market, pest analysis
  • FIG 8. Global Antihypertensive Drugs market, value chain analysis
  • FIG 9. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 10. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 11. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 12. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 13. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 14. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 15. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 16. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 17. Global Antihypertensive Drugs market, regional snapshot 2017 & 2027
  • FIG 18. North America Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 19. Europe Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 20. Asia-Pacific Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 21. Latin America Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 22. Global Antihypertensive Drugs market, company market share analysis (2019)